FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

BMS Opdivo High Risk Urothelial Carcinoma OKd

[ Price : $8.95]

FDA approves Bristol-Myers Squibbs Opdivo (nivolumab) for the adjuvant treatment of patients with urothelial carcinoma who are at ...

FDA Says Pfizer Expands Chantix Recall Again

[ Price : $8.95]

FDA says Pfizer has recalled four additional lots of Chantix due to the presence of an unacceptable level of N-nitroso-varenicline...

FDA Fast Track Designation for Senhwas Silmitasertib

[ Price : $8.95]

FDA grants fast track designation to Senhwa Biosciences silmitasertib for treating recurrent sonic hedgehog medulloblastoma.

FDA Clears Qure.ai qER-Quant for Brain CT Scans

[ Price : $8.95]

FDA clears a Qure.ai brain imaging quantification product.

Drug, Device Recalls Continue to Go Down: Sedgwick

[ Price : $8.95]

The Sedgwick recall index says both medical device and pharmaceutical recalls continued to drop in the second quarter of 2021, hit...

FDA Clears Zimmer Biomet Rosa Hip

[ Price : $8.95]

FDA clears a Zimmer Biomet 510(k) for its Rosa Hip System for robotically-assisted direct anterior total hip replacement.

CardioNXT Heart Treatment Navigation System Cleared

[ Price : $8.95]

FDA clears a CardioNXT 510(k) for its heart treatment delivery platform.

Petition Wants NAC Declared Legal Dietary Ingredient

[ Price : $8.95]

The Natural Products Association asks FDA to declare N-acetyl-L-cysteine a legal dietary supplement ingredient.

AdvaMed Comments on CDRH Discussion Paper

[ Price : $8.95]

AdvaMed provides comments in three categories on a CDRH discussion paper on a framework for conveying materials information to pat...

FDA Grants Covis Hearing Request on Makena

[ Price : $8.95]

FDA approves a Covis Pharma request for a hearing on CDERs proposal to withdraw approval for Makena.